Fecal microbiota spores, live
Medication / From Wikipedia, the free encyclopedia
Live fecal microbiota spores, sold under the brand name Vowst, is a fecal microbiota product used to prevent the recurrence of Clostridioides difficile infection (C. difficile).[1][2]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Vowst |
Other names | SER-109, fecal microbiota spores, live-brpk |
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status |
Close
Live fecal microbiota spores, contain live bacteria and are manufactured from human fecal matter donated by qualified individuals.[2]
Vowst was approved for medical use in the United States in April 2023.[1][2][3] It is the first fecal microbiota product that is taken by mouth (orally).[2]